Guangzhou Baiyunshan Pharmaceutical
(OTC) GZPHF
Guangzhou Baiyunshan Pharmaceutical Financials at a Glance
Market Cap
$3.80B
Revenue (TTM)
$77.41B
Net Income (TTM)
$2.99B
EPS (TTM)
$0.25
P/E Ratio
9.23
Dividend
$0.11
Beta (Volatility)
0.11 (Low)
Dividend
$0.11
Beta (Volatility)
0.11 (Low)
Price
$2.34
Volume
300
Open
$2.34
Price
$2.34
Volume
300
Open
$2.34
Previous Close
$2.34
Daily Range
$2.34 - $2.34
52-Week Range
$2.14 - $2.64
Dividend
$0.11
Beta (Volatility)
0.11 (Low)
Price
$2.34
Volume
300
Open
$2.34
Previous Close
$2.34
Daily Range
$2.34 - $2.34
52-Week Range
$2.14 - $2.64
GZPHF News
GZPHF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Guangzhou Baiyunshan Pharmaceutical
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
27,057
CEO
Hong Li, EMBA
Website
www.gybys.com.cnHeadquarters
Guangzhou, 510130, CN
GZPHF Financials
Key Financial Metrics (TTM)
Gross Margin
16%
Operating Margin
4%
Net Income Margin
4%
Return on Equity
8%
Return on Capital
7%
Return on Assets
4%
Earnings Yield
10.83%
Dividend Yield
0.05%
Payout Ratio
68.40%
Stock Overview
Market Cap
$3.80B
Shares Outstanding
1.63B
Volume
300
Short Interest
0.00%
Avg. Volume
4.918
Financials (TTM)
Gross Profit
$11.46B
Operating Income
$3.02B
EBITDA
$3.95B
Operating Cash Flow
$253.52M
Capital Expenditure
$1.21B
Free Cash Flow
$954.41M
Cash & ST Invst.
$23.82B
Total Debt
$20.70B
Guangzhou Baiyunshan Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.81B
-0.7%
Gross Profit
$1.58B
-23.3%
Gross Margin
10.01%
N/A
Market Cap
$3.80B
N/A
Market Cap/Employee
$135.20K
N/A
Employees
28,138
N/A
Net Income
$322.14M
+0.4%
EBITDA
$488.01M
-63.9%
Quarterly Fundamentals
Net Cash
$3.12B
-47.2%
Accounts Receivable
$23.45B
+14.7%
Inventory
$13.14B
+2.6%
Long Term Debt
$3.55B
+9.1%
Short Term Debt
$17.15B
+88.0%
Return on Assets
3.53%
N/A
Return on Invested Capital
7.29%
N/A
Free Cash Flow
$1.48B
-61.8%
Operating Cash Flow
$1.81B
N/A